BNP Paribas China Equity vs BGF World Healthscience

BNP Paribas China Equity vs BGF World Healthscience

1. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    17

2. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

Fund Holdings

We have information about 23 holdings in BNP Paribas China Equity, where the largest holding is Tencent (9.45), followed by Alibaba Group Holding Ltd (9.07) and Xiaomi (6.25). In comparison with BGF World Healthscience, we have 20 holdings where UnitedHealth is the largest holding (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67).

All Holdings

Here we compare the holdings in BNP Paribas China Equity and BGF World Healthscience.

BNP Paribas China Equity BGF World Healthscience
1. Tencent Holdings Ltd
China
9.45 %
1. UnitedHealth Group Inc
USA
8.2 %
2. Alibaba Group Holding Ltd
China
9.07 %
2. Eli Lilly and Co
USA
7.01 %
3. Xiaomi
China
6.25 %
3. Novo Nordisk B
Denmark
6.67 %
4. China Merchants Bank Class H
China
5.33 %
4. Merck & Co Inc
Germany
3.99 %
5. Industrial and Commercial Bank of China Ltd Class H
China
4.38 %
5. Boston Scientific Corp
3.67 %
6. Pop Mart International Group Ltd
China
4.12 %
6. AbbVie Inc
USA
3.61 %
7. Trip.com Group Ltd
Singapore
2.96 %
7. Amgen Inc
USA
3.58 %
8. NetEase ADR
China
2.92 %
8. Sanofi SA
France
3.05 %
9. Ping An Insurance Co
China
2.6 %
9. Abbott Laboratories
USA
3.02 %
10. Meituan Class B
China
2.57 %
10. AstraZeneca
Sweden UK
2.98 %
11. KE Holdings Inc ADR
China
2.13 %
-
12. Taiwan Semiconductor Manufacturing Company
Taiwan
1.91 %
-
13. China Yangtze Power Co Ltd Class A
China
1.66 %
-
14. Fuyao Glass Industry Group Co Ltd Class A
China
1.65 %
-
15. BYD Co Ltd Class H
China
1.57 %
-
16. Contemporary Amperex Technology Co Ltd Class A
China
1.51 %
-
17. Pinduoduo Inc
China
1.5 %
-

The list of fund holdings was last updated on July 27, 2025.